Treatment outcomes among a cohort of African American buprenorphine patients: Follow-up at 12 months
Background: Although buprenorphine/naloxone (bup/nal) is well-established as a safe and effective treatment for opioid use disorders (OUDs), there are few studies reporting 12-month outcomes of patients receiving bup/nal in formerly drug-free outpatient programs. Objectives: To examine 12-month outc...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor and Francis Ltd
2018
|
Subjects: | |
Online Access: | View Fulltext in Publisher |